Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.495 USD | +3.46% | -17.79% | -46.03% |
Mar. 18 | Transcript : Biofrontera Inc., Q4 2023 Earnings Call, Mar 18, 2024 | |
Mar. 15 | Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.03% | 7.61M | |
+27.92% | 672B | |
+26.76% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+7.36% | 217B | |
+6.27% | 199B | |
-8.96% | 204B | |
-8.58% | 149B |
- Stock Market
- Equities
- BFRI Stock
- News Biofrontera Inc.
- Biofrontera Says FDA Has Approved German Facility as Contract Laboratory for Testing of Ameluz Gel; Shares Surge